Cancer-Channel Icon 

Recently, the heterogeneity and complexity of malignant tumors has changed the way we think about the initiation, progression, diagnosis, and management of cancer. The Cancer Channel will explore the emerging molecular markers, improved preclinical models, and genomic-based therapies that are increasing the success of personalized medicine.

Cancer Molecular Markers

Circulating Tumor Cells

Immunotherapy Therapeutics - New

Predictive Preclinical Models in Oncology


Premier Sponsors:   


Jackson Laboratory - small logo  



 Precision for Medicine 


Silicon Biosystems 

Thomson Reuters-Large